Proresolution Therapy for the Treatment of Delayed Healing of Diabetic Wounds
Open Access
- 17 January 2013
- journal article
- Published by American Diabetes Association in Diabetes
- Vol. 62 (2), 618-627
- https://doi.org/10.2337/db12-0684
Abstract
Obesity and type 2 diabetes are emerging global epidemics associated with chronic, low-grade inflammation. A characteristic feature of type 2 diabetes is delayed wound healing, which increases the risk of recurrent infections, tissue necrosis, and limb amputation. In health, inflammation is actively resolved by endogenous mediators, such as the resolvins. D-series resolvins are generated from docosahexaenoic acid (DHA) and promote macrophage-mediated clearance of microbes and apoptotic cells. However, it is not clear how type 2 diabetes affects the resolution of inflammation. Here, we report that resolution of acute peritonitis is delayed in obese diabetic (db/db) mice. Altered resolution was associated with decreased apoptotic cell and Fc receptor–mediated macrophage clearance. Treatment with resolvin D1 (RvD1) enhanced resolution of peritonitis, decreased accumulation of apoptotic thymocytes in diabetic mice, and stimulated diabetic macrophage phagocytosis. Conversion of DHA to monohydroxydocosanoids, markers of resolvin biosynthesis, was attenuated in diabetic wounds, and local application of RvD1 accelerated wound closure and decreased accumulation of apoptotic cells and macrophages in the wounds. These findings support the notion that diabetes impairs resolution of wound healing and demonstrate that stimulating resolution with proresolving lipid mediators could be a novel approach to treating chronic, nonhealing wounds in patients with diabetes.Keywords
This publication has 36 references indexed in Scilit:
- Defective Phagocytosis of Apoptotic Cells by Macrophages in Atherosclerotic Lesions of ob/ob Mice and Reversal by a Fish Oil DietCirculation Research, 2009
- Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsisNature, 2009
- Obesity‐induced insulin resistance and hepatic steatosis are alleviated by ω‐3 fatty acids: a role for resolvins and protectinsThe FASEB Journal, 2009
- Unresolved issues in the management of ulcers of the foot in diabetesDiabetic Medicine, 2008
- Nutrient sensing and inflammation in metabolic diseasesNature Reviews Immunology, 2008
- Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediatorsNature Reviews Immunology, 2008
- n-3 Fatty Acids in the Treatment of Diabetic PatientsDiabetes Care, 2007
- Resolution of in flammation: state of the art, definitions and termsThe FASEB Journal, 2007
- Burying the DeadSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2006
- Low phagocytic activity of resident peritoneal macrophages in diabetic mice: relevance to the formation of advanced glycation end products.Diabetes, 1999